Unwinding the patient journey: Simplifying experiences and overcoming patient access barriers

At the recent ThinkLive Cell and Gene Therapy Summit 2024 – “Beyond borders: Breaking barriers to enhance patient access in cell and gene therapy” –, a panel of industry experts from the National Organization for Rare Disorders (NORD), the Emily Whitehead Foundation, TrakCel and Cencora, explored the intricate landscape of patient experiences in cell and gene therapies.

Dale Hanna, Director of Cell and Gene Therapy Solutions at Cencora, set the tone by highlighting the pivotal role of trust and support in guiding patients towards treatment success. The conversation delved into the critical importance of patient education, personalized support mechanisms, and empowering individuals navigating the complexities of advanced therapies. The panelists discussed differences between traditional and innovative treatments, emphasizing tailored care, patient engagement, and individualized support strategies.

Addressing logistical complexities in treatment delivery and post-treatment support, were thoroughly examined, with a focus on bridging gaps in patient care. Technology emerged as a key enabler in optimizing data exchange, enhancing stakeholder coordination, and improving access and monitoring protocols.

Envisioning a future of personalized, technology-driven patient journeys, the panelists advocated for innovation, collaboration, and a steadfast commitment to delivering exceptional patient care in cell and gene therapies.

For an in-depth exploration of the insights shared during this panel discussion, we invite you to watch the recording of the session to gain valuable perspectives on the evolving landscape of patient care in cell and gene therapies.

Building patient trust and empowerment to improve the treatment experience

Cell and gene therapies have brought transformational advancement to the care of patients with rare diseases, including, in some cases, curative treatments. These therapies are, however, not well understood by patients and their caregivers, and there is also often uncertainty in the physician and payer communities.

Read now

Recap: ThinkLive Cell and Gene Therapy Summit 2024

Explore highlights from the Inaugural ThinkLive Cell and Gene Therapy Summit, which unfolded on May 14-15, 2024. Over two days, global and emerging company leaders, providers, and experts converged at this virtual summit to delve into the future of healthcare. The event served as a platform where over 30 speakers across 10 sessions explored six key focus areas at the forefront of healthcare innovation.